Ganga Pharmaceuticals has confirmed no deviation in the use of funds raised through its preferential issue of equity shares and convertible warrants totaling Rs. 1.71 crore.

The company utilized Rs. 48.75 lakh for expanding manufacturing facilities, Rs. 81.25 lakh for working capital, and Rs. 40.62 lakh for general corporate purposes, fully deploying the amounts allocated within the planned timeframe.

This disciplined fund utilization supports the company’s growth plans and operational strength, ensuring transparency and confidence for shareholders.